Bulletin
Investor Alert

HilleVax Inc.

NAS: HLVX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 7, 2022, 4:10 p.m.

/zigman2/quotes/234952647/composite

$

16.19

Change

+0.09 +0.56%

Volume

Volume 25

Quotes are delayed by 20 min

/zigman2/quotes/234952647/composite

Today's close

$ 18.83

$ 16.10

Change

-2.73 -14.50%

Day low

Day high

$15.71

$18.64

Open

52 week low

52 week high

$7.90

$24.42

Open

Robert M. Hershberg

Founder of VentiRx Pharmaceuticals, Inc., Robert M. Hershberg is Chairman, President & Chief Executive Officer of HilleVax, Inc. He is also Member of UW Medicine and on the board of 5 other companies.

In the past he occupied the position of President, Chief Executive Officer & Director at VentiRx Pharmaceuticals, Inc., Chief Scientific Officer & Executive VP at Celgene Corp., Chief Medical Officer & Senior Vice President of Dendreon Corp., Vice President-Medical Genetics at Corixa Corp. and Assistant Professor at Harvard Medical School.

He received an undergraduate degree and a doctorate from the University of California, Los Angeles and a doctorate from The Salk Institute for Biological Studies.

Transactions

Date Shares Transaction Value

Officers and Executives

Dr. Robert M. Hershberg
Chairman, President & Chief Executive Officer
Dr. Aditya Kohli
Chief Operating Officer & Director
Mr. David A. Socks
Chief Financial & Business Officer
Dr. Astrid Borkowski
Chief Medical Officer
Mr. Paul S. Bavier
Secretary & Chief Administrative Officer
Dr. Gary Dubin
Director
Ms. Kaia Agarwal
Senior Vice President-Regulatory Affairs
Dr. Shelley Chu
Independent Director
Dr. Julie Louise Gerberding
Independent Director
Mr. Patrick J. Heron
Independent Director
Ms. Jeryl Lynn Hilleman
Independent Director
Dr. Jaime Sepulveda
Independent Director
Ms. Susan Silbermann
Independent Director
Link to MarketWatch's Slice.